Investigators detail some of the hopes – and fears – behind Cellectis' off-the-shelf CAR-T
Cellectis is right at the cutting edge of developing a new, off-the-shelf CAR-T that hopes to disrupt a market that has yet to be created …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.